CHEMGENEX PHARMACEUTICALS LTD - Announcements

Currently unlisted. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

CXS	Suspension at close of trading 21/6/11	PRICE SENSITIVE	21/06/11	132.17KB	Share
CXS	Notice of Compulsory Acquisition	PRICE SENSITIVE	14/06/11	71.23KB	Share
CXS	Notice of Variation of Offer: Extension of Offer Period	PRICE SENSITIVE	14/06/11	65.66KB	Share
CXS	Notice Under Sec 630(3) - Status of Defeating Conditions	PRICE SENSITIVE	06/06/11	76.32KB	Share
CXS	Notice under Sec 650F re Cephalon T/O	PRICE SENSITIVE	01/06/11	42.94KB	Share
CXS	Extension of Office Period	PRICE SENSITIVE	27/05/11	124.7KB	Share
CXS	Notice under Section 650F of Corps Act	PRICE SENSITIVE	27/05/11	46.82KB	Share
CXS	Cephalon CXS Holdings PL Notice of Acceptances	PRICE SENSITIVE	27/05/11	56.98KB	Share
CXS	Supplementary Bidder's Statement	PRICE SENSITIVE	20/05/11	148.28KB	Share
CXS	Variation of Takeover Bid	PRICE SENSITIVE	13/05/11	116.73KB	Share
CXS	Supplementary Bidder's Statement	PRICE SENSITIVE	04/05/11	91.39KB	Share
CXS	First Supplementary Bidder's Statement	PRICE SENSITIVE	29/04/11	160.41KB	Share
CXS	Off market takeover bid by Cephalon	PRICE SENSITIVE	27/04/11	55.65KB	Share
CXS	Bidder's Statement and Target's Statement	PRICE SENSITIVE	13/04/11	1.17MB	Share
CXS	Cephalon Update	PRICE SENSITIVE	30/03/11	97.01KB	Share
CXS	Cephalon Launches Takeover Bid	PRICE SENSITIVE	29/03/11	233.06KB	Share
CXS	Trading Halt	PRICE SENSITIVE	25/03/11	18.25KB	Share
CXS	Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/11	156.92KB	Share
CXS	ChemGenex to Align European and US Regulatory Strategies	PRICE SENSITIVE	05/01/11	46.3KB	Share
CXS	Awarded U.S. Therapeutic Discovery grant	PRICE SENSITIVE	02/11/10	152.23KB	Share
CXS	Convertible Note Issued to Cephalon, Inc	PRICE SENSITIVE	22/10/10	190.64KB	Share
CXS	Response to an ASX Price Query	PRICE SENSITIVE	05/10/10	213.31KB	Share
CXS	ChemGenex Completes pre-NDA Meeting with U.S. FDA	PRICE SENSITIVE	05/10/10	149.61KB	Share
CXS	Preliminary Final Report	PRICE SENSITIVE	27/08/10	375.82KB	Share
CXS	FDA agrees on potential regulatory pathway for OMAPRO	PRICE SENSITIVE	14/07/10	1.35MB	Share
CXS	Complete Response Letter from FDA Received	PRICE SENSITIVE	12/04/10	29.25KB	Share
CXS	ODAC seeks validated diganostic before approval of OMAPRO	PRICE SENSITIVE	23/03/10	113.69KB	Share
CXS	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/10	411.88KB	Share
CXS	ODAC Postponed Due to Extreme Weather in Washington DC	PRICE SENSITIVE	09/02/10	37.54KB	Share
CXS	Omapro ODAC meeting confirmed for 10 February 2010	PRICE SENSITIVE	17/12/09	37.87KB	Share
CXS	Omacetaxine European rights licensed to Hospira	PRICE SENSITIVE	14/12/09	42.85KB	Share
CXS	Updated omacetaxine data from multiTKI failure study	PRICE SENSITIVE	09/12/09	46.97KB	Share
CXS	Omapro Data Highlighted at ASH Press Conference	PRICE SENSITIVE	07/12/09	50.61KB	Share
CXS	EMEA validates ChemGenex's MAA for omacetaxine	PRICE SENSITIVE	27/11/09	42.05KB	Share
CXS	US FDA accepts Omapro NDA - grants priority review	PRICE SENSITIVE	10/11/09	41.66KB	Share
CXS	Preliminary Final Report	PRICE SENSITIVE	27/08/09	341.27KB	Share
CXS	Omacetaxine Kills Leukemic Stem Cells in Human CML Models	PRICE SENSITIVE	09/06/09	39.58KB	Share
CXS	Omacetaxine Shows Activity in Refractory CML	PRICE SENSITIVE	09/06/09	45.64KB	Share
CXS	Omacetaxine Clinical Data Presented at ASCO	PRICE SENSITIVE	02/06/09	45.34KB	Share
CXS	Rights Issue Fully Subscribed, Further $1 Million Placement	PRICE SENSITIVE	27/05/09	44.53KB	Share
CXS	Information Booklet for Shareholders	PRICE SENSITIVE	21/04/09	168.77KB	Share
CXS	Non-Renounceable Issue	PRICE SENSITIVE	21/04/09	44.38KB	Share
CXS	Placement and Non-Renounceable Rights Issue	PRICE SENSITIVE	09/04/09	33.06KB	Share
CXS	Reinstatement to Official Quotation	PRICE SENSITIVE	09/04/09	18.13KB	Share
CXS	Suspension from Official Quotation	PRICE SENSITIVE	08/04/09	42.18KB	Share
CXS	Trading Halt	PRICE SENSITIVE	06/04/09	43.36KB	Share
CXS	New Data Suggests Omacetaxine Eradicates Leukemic Stem Cells	PRICE SENSITIVE	27/03/09	43.86KB	Share
CXS	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/09	422.1KB	Share
CXS	FDA Grants Orphan Drug Designation to Omacetaxine for MDS	PRICE SENSITIVE	20/01/09	38.58KB	Share
CXS	Interim Clinical Trial Results Presented at ASH Conference	PRICE SENSITIVE	09/12/08	34.94KB	Share

CXSSuspension at close of trading 21/6/11
21/06/11	PRICE SENSITIVE	132.17KB	Share
CXSNotice of Compulsory Acquisition
14/06/11	PRICE SENSITIVE	71.23KB	Share
CXSNotice of Variation of Offer: Extension of Offer Period
14/06/11	PRICE SENSITIVE	65.66KB	Share
CXSNotice Under Sec 630(3) - Status of Defeating Conditions
06/06/11	PRICE SENSITIVE	76.32KB	Share
CXSNotice under Sec 650F re Cephalon T/O
01/06/11	PRICE SENSITIVE	42.94KB	Share
CXSExtension of Office Period
27/05/11	PRICE SENSITIVE	124.7KB	Share
CXSNotice under Section 650F of Corps Act
27/05/11	PRICE SENSITIVE	46.82KB	Share
CXSCephalon CXS Holdings PL Notice of Acceptances
27/05/11	PRICE SENSITIVE	56.98KB	Share
CXSSupplementary Bidder's Statement
20/05/11	PRICE SENSITIVE	148.28KB	Share
CXSVariation of Takeover Bid
13/05/11	PRICE SENSITIVE	116.73KB	Share
CXSSupplementary Bidder's Statement
04/05/11	PRICE SENSITIVE	91.39KB	Share
CXSFirst Supplementary Bidder's Statement
29/04/11	PRICE SENSITIVE	160.41KB	Share
CXSOff market takeover bid by Cephalon
27/04/11	PRICE SENSITIVE	55.65KB	Share
CXSBidder's Statement and Target's Statement
13/04/11	PRICE SENSITIVE	1.17MB	Share
CXSCephalon Update
30/03/11	PRICE SENSITIVE	97.01KB	Share
CXSCephalon Launches Takeover Bid
29/03/11	PRICE SENSITIVE	233.06KB	Share
CXSTrading Halt
25/03/11	PRICE SENSITIVE	18.25KB	Share
CXSHalf Yearly Report and Accounts
18/02/11	PRICE SENSITIVE	156.92KB	Share
CXSChemGenex to Align European and US Regulatory Strategies
05/01/11	PRICE SENSITIVE	46.3KB	Share
CXSAwarded U.S. Therapeutic Discovery grant
02/11/10	PRICE SENSITIVE	152.23KB	Share
CXSConvertible Note Issued to Cephalon, Inc
22/10/10	PRICE SENSITIVE	190.64KB	Share
CXSResponse to an ASX Price Query
05/10/10	PRICE SENSITIVE	213.31KB	Share
CXSChemGenex Completes pre-NDA Meeting with U.S. FDA
05/10/10	PRICE SENSITIVE	149.61KB	Share
CXSPreliminary Final Report
27/08/10	PRICE SENSITIVE	375.82KB	Share
CXSFDA agrees on potential regulatory pathway for OMAPRO
14/07/10	PRICE SENSITIVE	1.35MB	Share
CXSComplete Response Letter from FDA Received
12/04/10	PRICE SENSITIVE	29.25KB	Share
CXSODAC seeks validated diganostic before approval of OMAPRO
23/03/10	PRICE SENSITIVE	113.69KB	Share
CXSHalf Yearly Report and Accounts
25/02/10	PRICE SENSITIVE	411.88KB	Share
CXSODAC Postponed Due to Extreme Weather in Washington DC
09/02/10	PRICE SENSITIVE	37.54KB	Share
CXSOmapro ODAC meeting confirmed for 10 February 2010
17/12/09	PRICE SENSITIVE	37.87KB	Share
CXSOmacetaxine European rights licensed to Hospira
14/12/09	PRICE SENSITIVE	42.85KB	Share
CXSUpdated omacetaxine data from multiTKI failure study
09/12/09	PRICE SENSITIVE	46.97KB	Share
CXSOmapro Data Highlighted at ASH Press Conference
07/12/09	PRICE SENSITIVE	50.61KB	Share
CXSEMEA validates ChemGenex's MAA for omacetaxine
27/11/09	PRICE SENSITIVE	42.05KB	Share
CXSUS FDA accepts Omapro NDA - grants priority review
10/11/09	PRICE SENSITIVE	41.66KB	Share
CXSPreliminary Final Report
27/08/09	PRICE SENSITIVE	341.27KB	Share
CXSOmacetaxine Kills Leukemic Stem Cells in Human CML Models
09/06/09	PRICE SENSITIVE	39.58KB	Share
CXSOmacetaxine Shows Activity in Refractory CML
09/06/09	PRICE SENSITIVE	45.64KB	Share
CXSOmacetaxine Clinical Data Presented at ASCO
02/06/09	PRICE SENSITIVE	45.34KB	Share
CXSRights Issue Fully Subscribed, Further $1 Million Placement
27/05/09	PRICE SENSITIVE	44.53KB	Share
CXSInformation Booklet for Shareholders
21/04/09	PRICE SENSITIVE	168.77KB	Share
CXSNon-Renounceable Issue
21/04/09	PRICE SENSITIVE	44.38KB	Share
CXSPlacement and Non-Renounceable Rights Issue
09/04/09	PRICE SENSITIVE	33.06KB	Share
CXSReinstatement to Official Quotation
09/04/09	PRICE SENSITIVE	18.13KB	Share
CXSSuspension from Official Quotation
08/04/09	PRICE SENSITIVE	42.18KB	Share
CXSTrading Halt
06/04/09	PRICE SENSITIVE	43.36KB	Share
CXSNew Data Suggests Omacetaxine Eradicates Leukemic Stem Cells
27/03/09	PRICE SENSITIVE	43.86KB	Share
CXSHalf Yearly Report and Accounts
25/02/09	PRICE SENSITIVE	422.1KB	Share
CXSFDA Grants Orphan Drug Designation to Omacetaxine for MDS
20/01/09	PRICE SENSITIVE	38.58KB	Share
CXSInterim Clinical Trial Results Presented at ASH Conference
09/12/08	PRICE SENSITIVE	34.94KB	Share

REFRESH

CHEMGENEX PHARMACEUTICALS LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available